| For: | Xu AX, Zhao ZF, Zhu L, Zhang YH, Li Y, Wei YF, Zhang BY, Jiang B, Gao TZ, Li MS, Liu JY. Promise and challenges of traditional Chinese medicine, specifically Calculus bovis, in liver cancer treatment. World J Gastroenterol 2024; 30(40): 4380-4385 [PMID: 39494098 DOI: 10.3748/wjg.v30.i40.4380] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i40/4380.htm |
| Number | Citing Articles |
| 1 |
Shunxin Li, Fanchen Zeng. Rhaponticin Reverses the Hypoxia-mediated Sorafenib Resistance of Hepatocellular Carcinoma Cells by Inhibiting Epithelial–Mesenchymal Transition. Pharmacognosy Magazine 2026; 22(2): 583 doi: 10.1177/09731296251348093
|
| 2 |
Xiwen Zeng, Sizhuo Liu, Qianhui He, Yanwen Ling, Jingqi Sun, Yang Ping, Jin Su. Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid–Gambogic Acid Nanocrystals. Pharmaceutics 2026; 18(2): 253 doi: 10.3390/pharmaceutics18020253
|
| 3 |
Boyang Su, Song Wang, Zhuang Xiong, Tiejun Liu, Yan Leng, Houbo Deng, Lu Liu, Xiaodan Sui. Hua Zheng San Ji Fang promotes ferroptosis through Keap1/Nrf2 pathway in hepatocellular carcinoma cells. Journal of Ethnopharmacology 2025; 352: 120165 doi: 10.1016/j.jep.2025.120165
|
| 4 |
Hongting Yan, Yingjie Li, Bin Guo, Bing Yang, Dongxin Tang. The effect of Traditional Chinese Medicine on patients undergoing targeted therapy for primary liver cancer: a systematic review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1674965
|
| 5 |
Xiaolin Liu, Kehui Zhang, Zongyao Wang, Yiyuan Zheng, Liubing Lin, Jian Wang, Xiangxue Pan, Yong Li. Combination of Traditional Chinese Medicine and Transarterial Chemoembolization for Hepatocellular Carcinoma: A Bibliometric Analysis. Journal of Hepatocellular Carcinoma 2026; : 1 doi: 10.2147/JHC.S598236
|
